KERX (Keryx Biopharmaceuticals, Inc.): Congressional Trading Activity
Who traded KERX?
KERX (Keryx Biopharmaceuticals, Inc.) appears in 4 STOCK Act disclosures from 1 filer (4 purchases, 0 sales), most recently Debbie Wasserman Schultz on Feb 10, 2017.
- Debbie Wasserman Schultz — 4 trades, last on Feb 10, 2017
Disclosed trades
| Filer | Trade date | Type | Amount |
|---|---|---|---|
| Debbie Wasserman Schultz | Feb 10, 2017 | Purchase | $1,001 - $15,000 |
| Debbie Wasserman Schultz | Dec 12, 2016 | Purchase | $1,001 - $15,000 |
| Debbie Wasserman Schultz | Dec 12, 2016 | Purchase | $1,001 - $15,000 |
| Debbie Wasserman Schultz | Apr 27, 2016 | Purchase | $1,001 - $15,000 |